UBS Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-34,071
| Closed | -$158K | – | 7357 |
|
|
2019
Q1 | $158K | Buy |
34,071
+7,428
| +28% | +$34.4K | ﹤0.01% | 4002 |
|
|
2018
Q4 | $93K | Buy |
26,643
+1,033
| +4% | +$3.61K | ﹤0.01% | 4723 |
|
|
2018
Q3 | $258K | Buy |
25,610
+13,591
| +113% | +$137K | ﹤0.01% | 4057 |
|
|
2018
Q2 | $87K | Sell |
12,019
-924
| -7% | -$6.69K | ﹤0.01% | 4676 |
|
|
2018
Q1 | $78K | Buy |
12,943
+8,631
| +200% | +$52K | ﹤0.01% | 4568 |
|
|
2017
Q4 | $41K | Sell |
4,312
-11,771
| -73% | -$112K | ﹤0.01% | 5060 |
|
|
2017
Q3 | $143K | Buy |
16,083
+9,139
| +132% | +$81.3K | ﹤0.01% | 4228 |
|
|
2017
Q2 | $88K | Sell |
6,944
-5,102
| -42% | -$64.7K | ﹤0.01% | 4369 |
|
|
2017
Q1 | $127K | Sell |
12,046
-39,126
| -76% | -$413K | ﹤0.01% | 4087 |
|
|
2016
Q4 | $471K | Sell |
51,172
-5,888
| -10% | -$54.2K | ﹤0.01% | 3358 |
|
|
2016
Q3 | $672K | Buy |
57,060
+9,965
| +21% | +$117K | ﹤0.01% | 2967 |
|
|
2016
Q2 | $610K | Sell |
47,095
-1,231
| -3% | -$15.9K | ﹤0.01% | 3030 |
|
|
2016
Q1 | $772K | Sell |
48,326
-79,014
| -62% | -$1.26M | ﹤0.01% | 2839 |
|
|
2015
Q4 | $3.65M | Buy |
127,340
+80,392
| +171% | +$2.3M | ﹤0.01% | 1739 |
|
|
2015
Q3 | $1.34M | Sell |
46,948
-2,083
| -4% | -$59.3K | ﹤0.01% | 2439 |
|
|
2015
Q2 | $1.76M | Sell |
49,031
-6,215
| -11% | -$223K | ﹤0.01% | 2408 |
|
|
2015
Q1 | $1.61M | Buy |
55,246
+3,570
| +7% | +$104K | ﹤0.01% | 2456 |
|
|
2014
Q4 | $1.09M | Buy |
+51,676
| New | +$1.09M | ﹤0.01% | 2686 |
|